Diagnosis and management of the drug overdose patient

American Journal of Therapeutics

Volumn 4, Issue 2-3, 1997, Pages 99-113

  Merigian, Kevin S ^a   Blaho, Kari ^a  

^a UT Medical Group   (United States)

Author keywords

drug confirmation; drug overdose; drug poisoning; drug screening; gastric emptying

Indexed keywords

AMPHETAMINE; AMYL NITRITE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ATROPINE; BOTULINUM TOXIN; CAFFEINE; CARBAMIC ACID DERIVATIVE; CARBON MONOXIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; COCAINE; DIPHENOXYLATE; EPHEDRINE; ETHYLENE GLYCOL; HEAVY METAL; MESCALINE; MESUXIMIDE; METHAMPHETAMINE; METHANOL; MONOAMINE OXIDASE INHIBITOR; NICOTINE; PARACETAMOL; PHENCYCLIDINE; PHENMETRAZINE; PHENOTHIAZINE; PHENTERMINE; PHENYLPROPANOLAMINE; SALBUTAMOL; THEOPHYLLINE; UNINDEXED DRUG;

ANTICHOLINERGIC EFFECT; COMA; DRUG OVERDOSE; HALLUCINOSIS; HUMAN; IMMOBILIZATION; MUSHROOM POISONING; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; SCREENING; SUSTAINED RELEASE PREPARATION;

EID: 0030977114     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199702000-00008     Document Type: Review

References (90)

1. DuPont RL: Substance abuse. JAMA 1985;254:235-237.
2. Rivara FP, Mueller BA, Fligner CL, et al.: Drug use in trauma victims. J Trauma 1989;29:462-470.
3. Brett AS: Implications of discordance between clinical impression and toxicology analysis in drug overdose. Arch Intern Med 1988;48:437-441.
4. Wright N: An assessment of the unreliability of the history given by self-poisoned patient. Clin Toxicol 1980; 16:381-384.
5. Teitelbaum DT, Morgan J, Gray G: Non-concordance between clinical impression and laboratory findings in clinical toxicology. Clin Toxicol 1977;10:417-422.
6. Osterloh JD: Utility and reliability of emergency toxicologic testing. Emerg Med Clin North Am 1990;8:693-723.
7. Kellermann AL, Fihn SD, Logerfro JP, et al.: Utilization and yield of drug screening in the emergency department. Am J Emerg Med 1988;6:14-20.
8. Kulig K: Utilization of emergency toxicology screens. Am J Emerg Med 1985;3:573-574.
9. Taylor RL, Cowan SL, White JD: Comprehensive toxicology screening in the emergency department: an aid to clinical diagnosis. Am J Emerg Med 1985;3:507-511.
10. Merigian KS, Woodard M, Hedges JR, et al.: Prospective evaluation of gastric emptying in the self-poisoned patient. Am J Emerg Med 1990;8:479-483.
11. Kulig K, Bar-Or D, Rosen P, et al.: Management of acutely poisoned patients without gastric emptying. Ann Emerg Med 1985;14:562-567.
12. Linden CH, Rumacv BH, Strehlke C: Monoamine oxidase inhibitor overdose. Ann Emerg Med 1984;13:1137-1144.
13. Cutler EA, Barrett GA, Graven PW, et al.: Delayed cardio pulmonary arrest after Lomotil® ingestion. Pediatrics 1980;65:157-158.
14. Ginsberg CM: Lomotil® intoxication. Am J Dis Child 1973;125:241-242.
15. Gawin FH, Ellinwood EH: Cocaine and other stimulants: addictions, abuse, treatment. N Engl J Med 1988;318: 1173-1182.
16. Mendelson JH: Biologic concomitants of alcoholism. N Engl J Med 1970;283:71-75.
17. Khantzian EJ, McKenna GJ: Acute toxic and withdrawal reactions associated with drug use and abuse. Ann Intern Med 1979;90:351-362.
18. Olson KR, Pentel PR, Kelly MT: Physical assessment and differential diagnosis of the poisoned patient. Med Toxicol 1987;2:58-81.
19. Appenzeller O: The normal pupil and some pupillary abnormalities. In: The Autonomic Nervous System, 3rd ed. (Ed. Appenzeller O). New York: Elsevier Biomedical Press, 1982, pp. 319-338.
20. Guyton AC: Body temperature, temperature regulation and fever. In: Textbook of Medical Physiology, 6th ed. (Ed. Guyton AC) WB Saunders, Philadelphia, 1992, pp. 797-807.
21. Benowitz NL, Osterloh J, Goldschlager N, et al.: Massive catacholamine release from caffeine poisoning. JAMA 1982;248:1097-1098.
22. Olsen KR, Benowitz NC, Woo OF, et al.: Theophylline overdose, acute single ingestion versus chronic repeated overmedication. Am J Emerg Med 1985;3:386-394.
23. Benowitz NL, Goldschlager N: Cardiac disturbances. In: Clinical Management of Poisoning and Drug Overdose, 2nd ed. (Eds. Haddad and Winchester). Philadelphia: WB Saunders, 1990, pp. 63-101.
24. Merigian KS, Roberts JR: Cocaine intoxication: hyperpyrexia, rhabdomyolysis and acute renal failure. Clin Toxicol 1987;25:135-148.
25. Garcia-Estrada H, Fishman CM: An unusual case of nicotine poisoning. Clin Toxicol 1977;10:391-393.
26. Lefkowitz RS, Hoffman BB, Taylor P: Neurohomoral transmission: the autonomic and somatic motor nervous systems. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. (Eds. Gilman AG, Rall TW, Nies AS, et al.) Pergamon Press, New York, 1990, pp. 84-121.
27. Savitt DL, Roberts JR, Merigian KS: Psychoactive drug abuse. In: Emergency Medicine Concepts and Clinical Practice, 3rd ed. (Eds. Rosen P, et al.), Mosby Year Book, Philadelphia, 1992, pp. 2035-2066.
28. Brown FC: Hallucinogenic Drugs. Charles C Thomas, Springfield, IL, 1972.
29. Schildkraut JJ: The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965;122:508-515.
30. Hollister LE: Treatment of depression with drugs. Ann Intern Med 1978;89:78-86.
31. Rothenberg RN: Hallucinogens. In: Emergency Medicine Concepts and Clinical Practice, 3rd ed. (Eds. Rosen P et al.), Mosby Year Book, Philadelphia, 1992, pp. 2573-2589.
32. Caldwell J, Sever PS: The biochemical pharmacology of abused drugs: amphetamines, cocaine and L.S.D. Clin Pharmacol Ther 1974;16:625-638.
33. Martin WR: Naloxone. Ann Intern Med 1976;85:765-770.
34. Waldron VD, Klint CR, Seibel JE: Methadone overdose treated by naloxone infusion. JAMA 1973;225:53-55.
35. Artman M, Boerth RC: Clonidine poisoning: a couples problem. Am J Dis Child 1983;137:171-173.
36. Olsson JM, Proitt AW: Management of clonidine ingestion in children. J Pediat 1983;103:646-648.
37. Patterson J: Myoclonus caused by tricyclic antidepressants. South Med J 1990;83:463-465.
38. Merigian KS, Woodard M, Hedges JR, et al.: Prospective evaluation of gastric emptying in the self-poisoned patient. Am J Emerg Med 1990;8:479-483.
39. Foulke GE, Albertson IE, Derlet RW: Use of ipecac increases emergency department stays and patient complication rates. [Abstract]. Ann Emerg Med 1988;17:402.
40. Albertson TE, Derlet RW, Foulke GE, et al.: Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute toxic ingestions. Ann Emerg Med 1989;18:56-59.
41. Smith TW, Butler VP, Haber E, et al.: Treatment of life-threatening digitalis intoxication with digoxin-specific fab antibody fragments: experience in 26 cases. N Engl J Med 1982;307:1357-1361.
42. Kulig K, Bar-Or D, Rosen P, et al.: Management of acutely poisoned patients without gastric emptying. Ann Emerg Med 1985;14:562-567.
43. Comstock EL, Boisaubin EV, Comstock BS, et al.: Assessment of the efficacy of activated charcoal following gastric lavage in acute drug emergencies. Clin Toxicol 1981; 19:149-165.
44. Shen FG: Treatment of acute poisoning. Med J Aust 1985;142:632-635.
45. Matthew H, Lawson AG (Eds.): Treatment of Common Acute Poisonings. Edinburgh: Churchill Livingston, 1979.
46. Eason JM, Lovejoy FH: Efficiency and safety of gastrointestinal decontamination in the treatment of oral poisoning. Pediat Clin North Am 1979;26:827-836.
47. Dawling S: Effect of delayed administration of activated charcoal and nortriptyline absorption. Eur J Clin Pharmacol 1978;14:445-447.
48. Winchester JF: Lithium. In: Clinical Management of Poisoning and Drug Overdose, 2nd ed., WB Saunders, Philadelphia, 1990, pp. 656-665.
49. Cutler EA, Barrett GA, Graven PW, et al.: Delayed cardiopulmonary arrest after Lomotil® ingestion. Pediatrics 1980;65:157-158.
50. Levy G, Tsuchiya T: Effect of activated charcoal on aspirin absorption in man. Clin Pharmacol Ther 1972;13: 317-321.
51. Fisher RH, Maetz HM, Trevting JJ, et al.: Activated charcoal in barbiturate and gluthimide poisoning of the dog. J Pediat 1971;78:1045-1049.
52. Dordoni B, Wilson RA, Thompson RP, et al.: Reduction of absorption of paracetamol by activated charcoal and cholestyramide: a possible therapeutic measure. Br Med J 1973;3:85-89.
53. Jones J, McMullen MJ, Dougherty J, Cannon L: Repetitive doses of activated charcoal in the treatment of poisoning. Am J Emerg Med 1987;5:305-310.
54. Neuvonen PJ, Elonen E: Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine, and phenylvotazone in man. Eur J Clin Pharmacol 1980;17:51-57.
55. Pond S, Jacobs M, Marks J, et al.: Treatment of digitoxin overdose with oral activated charcoal. Lancet 1981;2: 1177-1178.
56. Lake KD, Brown DC, Peterson CD: Digoxin toxicity: enhanced systemic elimination during oral activated charcoal therapy. Pharmacotherapy 1984;463:161-163.
57. Gal P, Miller A, Cue J: Oral activated charcoal to enhance theophylline elimination in an acute overdose. JAMA 1984;251(23):3130-3131.
58. Rosenberg PJ, Livingstone DJ, McLellan BA: Effect of whole-bowel irrigation on antidotal efficacy of oral activated charcoal. Ann Emerg Med 1988;17:681-685.
59. Postuma R: Whole-bowel irrigation in pediatric patients: a comparison of irrigating solutions. J Pediat Surg 1988; 23:769-772.
60. Marshall BE, Longnecker DE: General anesthetics-benzodiazepines. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. (Eds. Gilman AG, et al.). New York: Pergamon Press, 1990, pp. 303-305.
61. Baldessarini RJ: Drugs and the treatment of psychiatric disorders. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. (Eds. Gilman AG, et al.). New York: Pergamon Press, 1990, pp. 383-404.
62. Chesebro JH, Knatterud G, Roberts R: Thrombolysis in Myocardial Infraction (TIMI) trial. Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 1987;76:142-148.
63. Chesebro JH, Badimon L, Fuster V: New approaches to treatment of myocardial infraction. Am J Cardiol 1990; 65:12c-16c.
64. Jokes E: New Means of extracting opium from the stomach. Lond Med Phys J 1822;48:384-389.
65. Rubenstein DE, Schneider RS, Ullman EF: Homogenous enzyme immunoassay: a new immunochemical technique. Biochem Biophys Res Commun 1972;47:846-851.
66. Manno JE, Manno BR, Pintalo GG: Adaptation of Emit® drug abuse urine assays for use with a centrifugal analyzed. J Anal Toxicol 1979;3:115-118.
67. Zebelman AM, Troyer BL, Randall GL, et al.: Modification of Emit® drug urine assays for use on the Cobas-Bio® centrifugal analyzer. Ther Drug Monitor 1982;4:433-435.
68. Wong SH: The fluorescence polarization assay in TDM: recent developments. Lab Manag 1984;22(1):36-42.
69. Bakerman S: Substrate-labeled fluorescence immunoassay. Lab Manag 1983;21(10):13-16.
70. Kwong TC, Chamberlain RT, Frederick DL, et al.: Critical issues in urinalysis of abused substances: report by the substance-abuse testing committee.. Clin Chem 1988; 34(3):605-632.
71. Skelley DS, Brown LP, Besch PK: Radioimmunoassay. Clin Chem 1973;19:146-186.
72. Byers BJ: Radioimmunoassays. In: Guidelines for Analytical Toxicology Programs VII (Ed. Thoma JJ). Cleveland: CRC Press, 1977, pp. 207-223.
73. Blass KG: A rapid simple thin-layer chromatography drug screening procedure. J Chromatogr 1974;95:75-79.
74. Michaud JB, Jones DW: Thin layer chromatography for broad spectrum drug detection. Am Lab 1980;12:104-106.
75. Jones DW, Adams D, Martel PA, et al.: Drug population in one thousand geographically distributed urine specimens. J Anal Toxicol 1985;9:125-130.
76. Humpel C, Haring C, Saria A: Rapid and sensitive determination of clozapine in human plasma using high performance liquid chromatography and amperometric detection. J Chrom Biomed Appl 1989;491:235-239.
77. Selinger K, Legel G, Hill HH, et al.: High performance liquid Chromatographie method for the analysis of benztropine in human plasma. J Chrom Biomed Appl 1989; 491:248-252.
78. Breiter J: Evaluation of column extraction: a new proce dure for the analysis of drugs in body fluids. Forensic Sci 1976;7:131-140.
79. Finkle B, Cherry EJ, Taylor DM: A GLC based system for detection of poisons, drugs and human metabolites encountered in forensic toxicology. J Chromatogr Sci 1971; 9:393-419.
80. Castello CE: Routine use of a flexible gas chromatograph mass spectrometer-computer system to identify drugs and their metabolites in body fluids of overdose victims. Clin Chem 1974;20:255-265.
81. Ullucci PA: A comprehensive GC/MS drug screening procedure. J Anal Toxicol 1978;2:33-38.
82. Snyder JW, Vlasses PT: Role of the toxicology laboratory in the treatment of the poisoned patient. Arch Intern Med 1988;148:279-280.
83. Hepler BR, Sutheimer CA, Sunshine I: Role of the toxicology laboratory in the treatment of acute poisoning. Med Toxicol 1986;1:61-75.
84. Osterloh JD: Utility and reliability of emergency toxicologic testing. Emerg Med Clin North Am 1990;8:693-723.
85. Prescott LF: Treatment of severe acetaminophen poisoning with intravenous acetylcysteine. Arch Intern Med 1981;141(Suppl):386-389.
86. Parry MF, Wallach R: Ethylene glycol poisoning. Am J Med 1974;57:143-150.
87. Beck CE: Methanol poisoning. J Emerg Med 1983;1:5-58.
88. Surveillance of elevated blood lead levels among adults in United States, 1992. MMWR Morbid Mortal Wkly Rep 1992;41(17):285-288.
89. Merigian KS: Drug overdose, part I. In-Service Training and Continuing Education, AACC TDM/Toc 1992, 13(17):5-19.
90. Merigian KS: Drug overdose, part II. In-Service Training and Continuing Education, AACC TDM/Toc 1992, 13(18):5-14.